OAS2 and viral infectious disease: The potential role of OAS3 in the recognition of CpG- and UpA-high mutants is consistent with its demonstrated preferential role in mediating RNAseL responses to a wide range of virus infections, and the frequent inactivity of OAS1 (and OAS2) in antiviral defence (25–27).